Navigation Links
Bio Base Europe: Flanders and the Netherlands Cooperate on Biofuels From Genetically Modified Poplars
Date:3/15/2010

AMSTERDAM, March 15, 2010 /PRNewswire/ -- Bio Base Europe is making progress in the development of sustainable biofuels. The recent first crop of genetically modified poplars of the Flemish Institute for Biotechnology (VIB) will be modified into bioethanol in a Flemish-Dutch pilot installation.

Bio Base Europe, a joint initiative of Biopark Terneuzen and Ghent Bio-Energy Valley, is a successful collaboration between The Netherlands and Flanders. Bio Base Europe is taking the lead in the development of a sustainable biobased economy in Europe.

Bio Base Europe consists of a pilot plant in Ghent for biobased products and processes on the one hand, and a training center for bio-process operators in Terneuzen on the other hand. Bio Base Europe represents a joint investment of 21 Million Euro and is unique in Europe. It was recently awarded with the European "Sail of Papenburg" cross border award.

The first crop of poplars for second generation bio-ethanol production has now been harvested!

In the pilot plant, scientists develop industrial processes to convert agricultural co-products such as wheat straw, corn cobs and wood into so-called second generation biofuels, bioplastics and other biobased products. For that, Bio Base Europe collaborates with the Flemish Institute for Biotechnology (VIB), renowned for its green biotechnology expertise. Prof. Wout Boerjan has developed genetically modified poplars that produce less lignin, facilitating their conversion into bioethanol. On May 6th, 2009 these poplars were planted for the first time in an open air field trial in Ghent. The first crop of this field trial has now been harvested and will be converted into bioethanol at the Bio Base Europe Pilot Plant. This draws us yet another step closer to the realization of second generation biofuels.

Prof. Wim Soetaert, Director of the Bio Base Europe Pilot Plant: "I am very happy with this new development on the long road towards second generation biofuels. It is not coincidentally the result of a Flemish-Dutch collaboration."

Or meet Prof. Wim Soetaert on Europa's largest Biofuels Congres in Amsterdam (http://www.worldbiofuelsmarkets.com/) on Monday 15 March at 2pm in the press room of the RAI Convention Centre, Europaplein 22, NL - 1078 GZ Amsterdam, The Netherlands.

A free press pass can be obtained with Mrs Laura Brownie, laura.brownie@greenpowerconferences.com

    http://www.bbeu.org
    http://www.vib.be
    http://www.bioparkterneuzen.com
    http://www.gbev.org

SOURCE Bio Base Europe

Back to top
'/>"/>
SOURCE Bio Base Europe
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment
2. GeneGo Collaborates With The Netherlands Toxicogenomics Center on $100 Million Grant
3. University Hospitals Case Medical Center, Cleveland, USA and Cardialysis BV, Rotterdam, the Netherlands Enter Strategic Alliance to Found Cardialysis Cleveland
4. Top Cancer Hospitals in Denmark and Netherlands First in Europe to Treat Patients With RapidArc(TM) Radiotherapy
5. Start of First Fingertip Payment Pilot in the Netherlands
6. Doctors in the US and Netherlands Using Fast RapidArc Radiotherapy Technology to Help Fight Cancer are Now Treating Tumors of the Head and Neck
7. Environmental Tectonics Corporations Simulation Division Receives New ADMS Contract from Netherlands Institute for Safety
8. Misonix Announces New Distribution Agreement for The Netherlands
9. Agendias Breast Cancer Test MammaPrint(R) Standard of Care at Netherlands Cancer Institute - AVL
10. Further 100 Million Euros Allocated to Netherlands-Based R&D Targeting the Early Diagnosis and Treatment of Disease
11. Accumetrics, Inc. Announces European Distribution Channels for France, Austria, Switzerland, Netherlands, Belgium and Luxembourg
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... (PRWEB) , ... October 12, ... ... today announces publication of a United States multicenter, prospective clinical study that ... disposable, point-of-care diagnostic test capable of identifying clinically significant acute bacterial and ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 system ... experiments and avoiding the use of exogenous expression plasmids. The simplicity of programming ... systematic gain-of-function studies. , This complement to loss-of-function studies, such as with ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 /PRNewswire/ ... London (ICR) and University of ... tool to risk-stratify patients with multiple myeloma (MM), in a ... . The University of Leeds is ... Myeloma UK, and ICR will perform the testing services to ...
(Date:10/10/2017)... (PRWEB) , ... October 10, ... ... development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed ... targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with ...
Breaking Biology Technology:
(Date:10/4/2017)... Oct. 4, 2017  GCE Solutions, a global clinical research organization ... document anonymization solution on October 4, 2017. Shadow is designed to ... comply with policy 0070 of the European Medicines Agency (EMA) in ... ... ...
(Date:6/23/2017)... and ITHACA, N.Y. , ... and Cornell University, a leader in dairy research, today ... bioinformatics designed to help reduce the chances that the ... the onset of this dairy project, Cornell University has ... for Sequencing the Food Supply Chain, a food safety ...
(Date:5/6/2017)... May 5, 2017 RAM Group ... a new breakthrough in biometric authentication based on ... mechanical properties to perform biometric authentication. These new sensors ... material created by Ram Group and its partners. This ... transportation, supply chains and security. Ram Group is ...
Breaking Biology News(10 mins):